<DOC>
	<DOCNO>NCT03097068</DOCNO>
	<brief_summary>The protocol measure number cytokine addition vascular endothelial growth factor response 0.3mg Lucentis .</brief_summary>
	<brief_title>Analysis Cytokines Response Treatment Diabetic Macular Edema With 0.3mg Lucentis</brief_title>
	<detailed_description>Lucentis injection current standard care diabetic macular edema . The deviation standard care current protocol aqueous tap first Lucentis injection fourth Lucentis injection diabetic macular edema .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Diagnosis diabetes mellitus Best correct visual acuity 20/32 20/320 Diabetic macular edema involve center macula Optical coherence tomography central subfield thickness least 250 micron History antivascular endothelial growth factor treatment past 12 month Any diabetic macular edema treatment past 4 month Heart attack , stroke , transient ischemic attack acute congestive heart failure within 4 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>